share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director MCGLYNN MARGARET G

Novavax | 4: Statement of changes in beneficial ownership of securities-Director MCGLYNN MARGARET G

诺瓦瓦克斯医药 | 4:持股变动声明-董事 MCGLYNN MARGARET G
美股sec公告 ·  06/14 16:21
Moomoo AI 已提取核心信息
On June 12, 2024, Margaret G. McGlynn, reported a completed transaction involving the acquisition of 6,670 shares of Novavax Inc (NVAX) common stock at a price of $0.00 per share. This transaction was categorized as an exercise or conversion of derivative security, conducted directly by McGlynn. Following this transaction, McGlynn's direct holdings in Novavax increased to a total of 10,470 shares. The transaction reflects a significant investment in the company by McGlynn, and it may indicate confidence in the future performance of Novavax.
On June 12, 2024, Margaret G. McGlynn, reported a completed transaction involving the acquisition of 6,670 shares of Novavax Inc (NVAX) common stock at a price of $0.00 per share. This transaction was categorized as an exercise or conversion of derivative security, conducted directly by McGlynn. Following this transaction, McGlynn's direct holdings in Novavax increased to a total of 10,470 shares. The transaction reflects a significant investment in the company by McGlynn, and it may indicate confidence in the future performance of Novavax.
2024年6月12日,玛格丽特·G·麦克格林(Margaret G. McGlynn)以每股0.00美元的价格完成了对诺瓦瓦克斯医药(Novavax Inc)普通股6,670股的收购交易。此交易被归类为衍生证券的行使或转换,由麦克格林直接进行。此后,麦克格林在诺瓦瓦克斯医药的直接持股总数增至10,470股。此次交易反映麦克格林对公司的重大投资,这可能表示她对诺瓦瓦克斯医药未来业绩的信恳智能。
2024年6月12日,玛格丽特·G·麦克格林(Margaret G. McGlynn)以每股0.00美元的价格完成了对诺瓦瓦克斯医药(Novavax Inc)普通股6,670股的收购交易。此交易被归类为衍生证券的行使或转换,由麦克格林直接进行。此后,麦克格林在诺瓦瓦克斯医药的直接持股总数增至10,470股。此次交易反映麦克格林对公司的重大投资,这可能表示她对诺瓦瓦克斯医药未来业绩的信恳智能。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息